Deniz Özer

Deniz Özer

Auto-generated profile, based on publicly available information

Deniz Özer

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Manisa Celal Bayar University, Hafsa Sultan Hospital, Manisa, Turkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
ŞAŞebnem Şenol Akar
Şebnem Şenol Akar
SASinem Akçalı
Sinem Akçalı
YÖYunus Özkaya
Yunus Özkaya
FGFatma Merve Gezginci
Fatma Merve Gezginci
BCBeyhan Cengiz
Beyhan Cengiz
EEErhan Eser
Erhan Eser
In this study, it was aimed to prospectively evaluate the efficacy, side effects and seroconversion data of inactive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), CoronaVac (R) (Sinovac, China) vaccine in healthcare workers. A total of 1053 healthcare workers who were initially seronegative (COV2T (R) SARS-CoV-2 Total Siemens, USA) and vaccinated with inactivated SARS-CoV-2 were included in the study. Quantitative IgG antibodies (ADVIA Centaur (R) SARS-CoV-2 IgG, Siemens, USA) were investigated 28 days after the first vaccine (n=939) and the second vaccine (n=771). In addition, neutralizing antibodies were evaluated via "enzyme linked immunosorbent assay (ELISA)" test (ACE2-RBD Neutralization Assay, Dia-Pro, Italy) 28 days after the first vaccine. Antibody response of the vaccine was evaluated statistically by univariate (Chi-square, Fisher's exact test, Student's t test, Mann-Whitney U, one-way ANOVA and Kruskall Wallis ANOVA tests) analysis and linear regression models. The consistency between quantitative IgG test and neutralizing antibody test was also evaluated in blood samples taken 28 days after second vaccination. Statistical analysis was determined in logarithmically transformed data with statistical analysis with SPSS 23.0 and Stata, and type 1 error level was accepted as 0.05. At least one side effect was reported by 31.3% and 26.8% of the participants after the first and second vaccine, respectively. The most frequent side effect was pain at the injection site with a frequency of 20.4% vs 21.7%. The frequency of applying to a health center due to side effects was 1.0% after the first vaccine and 0.8% after the second vaccine. The percentage of those who produced sufficient quantitative IgG was found as 25.3% (95% CI=22.5-28.1) 28 days after the first vaccine and 97.9% (95% CI=96.9198.93) after the second vaccine. Neutralizing test antibody positivity was found as 97.7% 28 days after the second vaccine. In univariate analysis, the characteristics that significantly increased the quantitative IgG response against inactivated SARS-CoV-2 vaccine were young age (p<0.01), female gender (p< 0.01), being a non-smoker (p<0.001), not having a chronic disease (p=0.019), having had the flu vaccine this year (p=0.012), not being overweight or obese (p=0.020), and having a SARS-CoV2 infection prior to vaccination (p<0.001). In addition, allied health personnel showed significantly lower antibody responses than the other workers (p<0.001). Multiple linear regression models revealed that, female gender, younger age, smoking and previous COVID-19 polymerase chain reaction test positivity significantly affected the quantitative IgG response after vaccination. A 99% agreement was found between the ELISA-based neutralizing antibody test and the quantitative IgG test (Kappa p=0.783) performed on the 28th day after the second vaccination. CoronaVac (R) provides adequate antibody response in 25% of healthcare workers aged 18-64, after 28 days from a single vaccine, and 97% after 28 days from the second vaccine. Antibody response was significantly higher in younger ages, women, non-smokers, and those who had previously encountered SARS-CoV-2. Phase 3 and phase 4 results are needed to show effectiveness of this vaccine in real life.

15 April 2023 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
KÇKübra Çiçek
Kübra Çiçek
YÖYunus Özkaya
Yunus Özkaya
EEErhan Eser
Erhan Eser
ZBZeynep Ceyda Buran
Zeynep Ceyda Buran
ZAZeynep Öykü Öztürk Arıkan
Zeynep Öykü Öztürk Arıkan
FYFerya Karadağ Yalçın
Ferya Karadağ Yalçın
This study was aimed to determine the efficacy of homologous (only CoronaVac or only Pfizer-BioN- Tech) and heterologous (CoronaVac and Pfizer-BioNTech) vaccines during the period when the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant was dominant in T0rkiye. Coro- navirus disease-2019 (COVID-2019) infection was confirmed by reverse transcriptase polymerase chain reaction and data on vaccination status against COVID-19 were evaluated during the period of 15 January 2022-1 May 2022 when the SARS-CoV-2 Omicron variant was dominant among 1854 employees fol- lowed in the SARS-CoV-2 Vaccine Cohort of Manisa Celal Bayar University (MCBU) Hospital Health Work-ers. Two separate reference groups were used in the evaluation of vaccine efficacy: those who were never vaccinated and those who received only two doses of CoronaVac. The efficacy of homologous and heter- ologous vaccine models was evaluated with relative risks and attributable risk percentages. MS Excel, SPSS 23.0 and STATA 14.1 package programs were used for statistical analysis. The mean age of the participants was 36.6 +/- 10.0. During the period from January 15th to May 1st 2022, 372 hospital workers were infected with COVID-19. Taking the never vaccinated as the reference group, the most effective model was found to be only the three or more doses of the Pfizer-BioNTech primary vaccination model (85.8%, 95% CI= 40.7-96.6). Models consisting of a single dose of CoronaVac (6.5%, 95% CI=-56.3-44.2) or a single dose of Pfizer-BioNTech (17.7%, 95% CI=-30.2-48.0) booster dose administered after two doses of primary CoronaVac vaccination was not found to be effective against the SARS-CoV-2 Omicron variant. When only two doses of primary CoronaVac vaccination model was taken as the reference group, the model consist-ing of two doses CoronaVac followed by two Pfizer-BioNTech booster doses was effective as 38.4% (95% CI= 15.4-55.3), whereas three doses of Pfizer-BioNTech booster model was effective as 56.4% (95% CI= 33.9-71.3). To conclude, none of the models other than the homologous or heterologous vaccine models containing at least three doses of Pfizer-BioNTech vaccine were effective compared to those unvaccinated. Compared with those who received only two doses of primary Coronavac, models with at least three dos-es of Pfizer-BioNTech reminder doses were more effective against the Omicron variant than other models.

25 March 2022 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
ŞAŞebnem Şenol Akar
Şebnem Şenol Akar
EDEmine Kübra Dindar Demiray
Emine Kübra Dindar Demiray
SASevil Alkan
Sevil Alkan
DÖDeniz Özer
Deniz Özer
SKSemra Kurutepe
Semra Kurutepe

14 April 2026 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
VAVeysel Akca
Veysel Akca
IAIlkay Akbulut
Ilkay Akbulut
GYGül Ruhsar Yilmaz
Gül Ruhsar Yilmaz
ATAlper Tahmaz
Alper Tahmaz
NÇNefi̇sE Öztoprak Çuvalci
Nefi̇sE Öztoprak Çuvalci
TTTurhan Togan
Turhan Togan
Background/aim: Post-exposure prophylaxis (PEP) for human immunodeficiency virus (HIV) plays a vital role in preventing transmission among healthcare workers following occupational exposure. Despite its clinical importance, epidemiological data regarding PEP implementation in Türkiye remain scarce. This study aimed to assess PEP practices, prophylactic treatment regimens, and follow-up outcomes among healthcare workers at risk of occupational HIV exposure. Materials and methods: This retrospective, multicenter study was conducted between January 2020 and December 2024 across 16 healthcare facilities participating in the National HIV/AIDS Working Group. Healthcare workers aged 18 years and older who presented for evaluation following occupational exposure to HIV were included. Data on demographics, exposure characteristics, source patient test results, PEP initiation timing, regimen preferences, adverse effects, and follow-up outcomes were collected from hospital records and analyzed using SPSS version 25.0. Results: A total of 369 healthcare workers were assessed. The PEP initiation rate was 49.1%. Needlestick injuries accounted for 79.4% of occupational exposures, and nurses constituted nearly half of presentations (49.6%). In univariable analyses, PEP initiation was less frequent among nurses than among other healthcare staff. In the multivariable model, male gender and age ≥40 years were independently associated with higher odds of PEP initiation, whereas nursing profession was associated with lower odds. The median time to PEP initiation was 17.9 hours (range: 0–120). Adverse effects were uncommon (3.5%), most frequently nausea and vomiting. No HIV seroconversions were identified among individuals with available follow-up results; however, follow-up testing at the predefined time points was incomplete, which limits the ability to exclude rare late seroconversions Conclusion: Timely initiation of HIV PEP appears feasible and well tolerated in real-world occupational settings. These findings highlight the need for standardized institutional protocols and improved follow-up strategies for healthcare workers in Türkiye.

1 December 2019 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
EGEzgi Gülten
Ezgi Gülten
EÖEsen Özgüven
Esen Özgüven
DTDeniz Özer Türk
Deniz Özer Türk
AAAbdullah Ömer Atsal
Abdullah Ömer Atsal

23 October 2025 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
DÖDeniz Özer
Deniz Özer
IÇİbRahim Çavuş
İbRahim Çavuş
AÖAhmet Özbi̇lGi̇n
Ahmet Özbi̇lGi̇n
Sıtma, enfekte dişi anofel cinsi sivrisineklerin taşıdığı Plasmodium parazitlerinin neden olduğu ciddi bir enfeksiyondur. Plasmodium falciparum, dünya genelindeki sıtma ölümlerinin ana nedenidir ve şiddetli olgularda koma, metabolik asidoz ve böbrek yetmezliği gibi komplikasyonlara yol açabilir. Bu çalışmada, yüksek parazitemili P.falciparum enfeksiyonu tanısı alan ve intravenöz (IV) artesunat ile tedavi edilen bir olgu sunulmuştur. Hasta, Liberya seyahati öyküsü olan 52 yaşında bir erkek olup, başvuru sırasında trombositopeni ve hemotokezya nedeniyle üniversite hastanesine sevk edilmiştir. Hasta daha sonra metabolik asidoz ve akut böbrek yetmezliği gibi şiddetli sıtma bulguları göstermiştir. Laboratuvar tetkiklerinde lökosit sayısı 9370/mm³, hemoglobin 18.3 g/dL, trombosit sayısı 11000/μL, aspartat aminotransferaz 57 U/L, alanin aminotransferaz 28 U/L, gama-glutamil transferaz 160 U/L, laktat dehidrogenaz 629 U/L, total bilirubin 8 mg/dL, direkt bilirubin 4.64 mg/dL, kreatinin 1.69 mg/dL, protrombin zamanı 14.9 saniye, uluslararası normalize oran 1.27 ve C-reaktif protein 247.7 mg/L olarak saptanmıştır. Hastadan yapılan Giemsa boyalı ince yayma kan preparatları, Abbott BiolineTM Malaria Ag P.f/P.v hızlı tanı kiti ve gerçek zamanlı polimeraz zincir reaksiyon analizi sonucu etken P.falciparum olarak saptanmıştır. IV artesunat ve sekonder enfeksiyonlara karşı meropenem tedavisi uygulanmış, tedaviye hızlı yanıt alınmıştır. Parazit yoğunluğu tedavi süresince düzenli olarak izlenmiş ve oral tedaviye geçilmiştir. Dünya Sağlık Örgütü ve Türkiye Halk Sağlığı Genel Müdürlüğünün sıtma tedavi algoritmalarına göre, şiddetli sıtma tedavisinde IV artesunat birinci tercih olarak önerilmektedir. Endemik bölgelere seyahat eden hastalarda açıklanamayan ateş ve grip benzeri semptomlar görüldüğünde, sıtma mutlaka ayırıcı tanıda düşünülmeli ve hızlı bir şekilde tanı konularak tedaviye başlanmalıdır. Erken tanı ve artesunatın hızlı etki gösteren mekanizması morbidite ve mortalite oranlarının önemli ölçüde düşürülmesine katkı sağlayacaktır. Bu olguda, artesunatın hızlı etkisi ve parazitemi takibindeki belirgin düşüş açıkça gözlemlenmiştir. Bu olgu raporunda, parazitemi izleminin, hasta tedavisinin yönlendirilmesinde kritik bir rol oynadığı ve klinisyenler ile mikrobiyologlar için önemli bir rehber niteliğinde olduğu değerlendirilmiştir.